1196506-93-0 Usage
Description
(R)-benzyl 3-(tert-butoxycarbonyl(ethyl)amino)piperidine-1-carboxylate is a chemical compound with the molecular formula C24H33NO4. It is a piperidine derivative that contains a benzyl group and a tert-butoxycarbonyl(ethyl)amino group. (R)-benzyl 3-(tert-butoxycarbonyl(ethyl)amino)piperidine-1-carboxylate is commonly used in organic chemistry as a building block for the synthesis of various pharmaceuticals and biologically active molecules. Its unique structure and properties make it a promising candidate for the development of new drugs and chemical agents.
Uses
Used in Pharmaceutical Industry:
(R)-benzyl 3-(tert-butoxycarbonyl(ethyl)amino)piperidine-1-carboxylate is used as a building block for the synthesis of various pharmaceuticals and biologically active molecules. Its unique structure and properties allow for the development of new drugs and chemical agents with potential applications in treating various medical conditions.
Used in Medicinal Chemistry Research and Development:
In the field of medicinal chemistry, (R)-benzyl 3-(tert-butoxycarbonyl(ethyl)amino)piperidine-1-carboxylate is used as a key component in the modification and synthesis of new molecules. Its potential for use in the development of novel drugs and chemical agents makes it a valuable asset in research and development efforts.
Check Digit Verification of cas no
The CAS Registry Mumber 1196506-93-0 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,1,9,6,5,0 and 6 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 1196506-93:
(9*1)+(8*1)+(7*9)+(6*6)+(5*5)+(4*0)+(3*6)+(2*9)+(1*3)=180
180 % 10 = 0
So 1196506-93-0 is a valid CAS Registry Number.
1196506-93-0Relevant articles and documents
PYRROLOPYRIDINES AS KINASE INHIBITORS
-
Page/Page column 76, (2009/12/23)
Compounds of Formula (I) are useful for inhibition of CHKl and/or CHK2. Methods of using compounds of Formula (I) and stereoisomers and pharmaceutically acceptable salts thereof, for in vitro, in situ, and in vivo diagnosis, prevention or treatment of such disorders in mammalian cells, or associated pathological conditions are disclosed.
